1. Home
  2. BOXL vs NXTS Comparison

BOXL vs NXTS Comparison

Compare BOXL & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boxlight Corporation

BOXL

Boxlight Corporation

HOLD

Current Price

$0.77

Market Cap

3.3M

ML Signal

HOLD

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$5.42

Market Cap

3.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BOXL
NXTS
Founded
1985
2009
Country
United States
Israel
Employees
N/A
9
Industry
Telecommunications Equipment
Agricultural Chemicals
Sector
Telecommunications
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
BOXL
NXTS
Price
$0.77
$5.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
68.1K
32.0K
Earning Date
04-16-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,743,612.00
N/A
Revenue This Year
$2.70
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
26.37
N/A
52 Week Low
$0.50
$0.55
52 Week High
$10.15
$6.75

Technical Indicators

Market Signals
Indicator
BOXL
NXTS
Relative Strength Index (RSI) 38.51 50.87
Support Level $0.70 $3.97
Resistance Level $0.95 $5.31
Average True Range (ATR) 0.07 0.68
MACD -0.00 -0.08
Stochastic Oscillator 23.53 22.45

Price Performance

Historical Comparison
BOXL
NXTS

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions, including flat-panels, LED video walls, and digital signage for the enterprise market. It has three reportable segments - Europe, Middle East and Africa (EMEA), and North and Central America (Americas). The majority of revenue is derived from the sale of education technology products in the EMEA segment.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: